• 1

    Validación empírica del CRAFFT Abuse Screening Test en una muestra de adolescentes españoles

    Adicciones 2019;31(2): 160-169

    medes_medicina en español

    RIAL A, KIM-HARRIS S, KNIGHT JR, ARAUJO M, GÓMEZ P, BRAÑA T, VARELA J, GOLPE S

    Adicciones 2019;31(2): 160-169

    Tipo artículo: Artículo

    Resumen del Autor: The CRAFFT Substance Abuse Screening Instrument, developed by the Center for Adolescents Substance Abuse Research (CeASAR) (Knight et al., 1999), is a screening tool for high-risk alcohol and drug risk consumption designed for use with adolescents. Since its publication it has been the subject of translations and validations in different countries, populations and contexts that have demonstrated its enormous potential. However, there is still no empirical validation study that would ensure its good psychometric performance in Spain. The aim of this paper is to develop an adapted version of the CRAFFT in Spanish and to analyze its psychometric properties in a sample of Spanish adolescents. For this purpose an individual interview was conducted on 312 adolescents aged between 12 and 18 years of age (M = 15.01; SD = 1.83) from the Galician community. The interview included a part of the Adolescent Diagnostic Interview (ADI) and the Problem Oriented Screening Instrument for Teenagers (POSIT). The results obtained, similar to those found in other countries, allow us to report that the Spanish version of the CRAFFT has a good psychometric behaviorproperties. It was found to have a satisfactory internal consistency with a Cronbach’s alpha value of .74. In terms of sensitivity and specificity, values of 74.4% and 96.4% respectively, were obtained and the area under the ROC curve was .946. The Spanish version of the CRAFFT is made available to researchers and professionals in the field of addictive behaviors, so that it can be used with the necessary psychometric guarantees.

    Notas:

     

    Palabras clave: Abuso de drogas, Adolescentes, Conducta adictiva, Cribado, Detección de abuso de drogas, España, Estudios de validación, Estudios prospectivos, Estudios transversales, Psicometría

    ID MEDES: 142479



    * RECUERDE. Al pulsar el enlace “Texto completo”, usted abandonará el entorno MEDES. En ese caso, la web a la que desea acceder no es propiedad de Fundación Lilly y, por tanto, ésta no se responsabiliza de los contenidos, informaciones o servicios presentes en ella, ni de la política de privacidad que aplique el sitio web de un tercero.